67 related articles for article (PubMed ID: 1924437)
21. Outcomes of patients with brain metastases from melanoma and renal cell carcinoma after primary stereotactic radiosurgery.
Jensen RL; Shrieve AF; Samlowski W; Shrieve DC
Clin Neurosurg; 2008; 55():150-9. PubMed ID: 19248682
[No Abstract] [Full Text] [Related]
22. Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma.
Hafez KS; Novick AC; Campbell SC
J Urol; 1997 Jun; 157(6):2067-70. PubMed ID: 9146581
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of DNA index in renal-cell carcinoma.
Devonec M; Bringuier PP; Hijazi A; Dutrieux-Berger N; Revillard JP; Perrin P
Prog Clin Biol Res; 1990; 348():35-48. PubMed ID: 2385607
[No Abstract] [Full Text] [Related]
24. Open partial nephrectomy for imperative and elective indications comparison of peri-operative data and long-term follow-up.
Denzinger S; Ganzer R; Fink A; Wieland WF; Blana A
Scand J Urol Nephrol; 2007; 41(6):496-500. PubMed ID: 17853016
[TBL] [Abstract][Full Text] [Related]
25. [Venous tumor invasion by renal cell carcinoma. Surgical technique, complications and survival rate].
Gschwend J; Maier S; Flohr P; de Petriconi R; Hautmann RE
Urologe A; 1994 Sep; 33(5):440-6. PubMed ID: 7974934
[TBL] [Abstract][Full Text] [Related]
26. Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis?
Skolarikos A; Alivizatos G; Bamias A; Mitropoulos D; Ferakis N; Deliveliotis C; Dimopoulos MA
Int J Urol; 2005 Jun; 12(6):563-9. PubMed ID: 15985079
[TBL] [Abstract][Full Text] [Related]
27. [Nephron-sparing surgery for small renal cell carcinoma: clinical analysis of 21 cases].
Xiao YJ; Zheng SB; Tan WL; Chen T; Qi H; Shao ZQ; Jiang YD; Wu P; Zhang HJ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):357-9. PubMed ID: 15772014
[TBL] [Abstract][Full Text] [Related]
28. [Transcriptome expression analyses of pulmonary renal cell carcinoma metastases].
Wuttig D; Höfling C; Füssel S; Meinhardt M; Herr A; Tennstedt P; Holotiuk O; Baretton G; Meye A; Grimm MO; Rolle A; Wirth MP
Urologe A; 2007 Sep; 46(9):1291-2. PubMed ID: 17619850
[No Abstract] [Full Text] [Related]
29. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
30. Cytogenetic, flow cytometric, and ultrastructural studies of twenty-nine nonfamilial human renal carcinomas.
Wolman SR; Camuto PM; Golimbu M; Schinella R
Cancer Res; 1988 May; 48(10):2890-7. PubMed ID: 3359446
[TBL] [Abstract][Full Text] [Related]
31. Simple enucleation for the treatment of PT1a renal cell carcinoma: our 20-year experience.
Carini M; Minervini A; Masieri L; Lapini A; Serni S
Eur Urol; 2006 Dec; 50(6):1263-8; discussion 1269-71. PubMed ID: 16787695
[TBL] [Abstract][Full Text] [Related]
32. Clinical and flow cytometric analyses of renal cell carcinomas with reference to incidental or non-incidental detection.
Sasaki Y; Homma Y; Hosaka Y; Tajima A; Aso Y
Jpn J Clin Oncol; 1994 Feb; 24(1):32-6. PubMed ID: 8126918
[TBL] [Abstract][Full Text] [Related]
33. Surgical care, morbidity, mortality and follow-up after nephrectomy for renal cancer with extension of tumor thrombus into the inferior vena cava: retrospective study since 1990s.
Rigaud J; Hetet JF; Braud G; Battisti S; Le Normand L; Glemain P; Karam G; Bouchot O
Eur Urol; 2006 Aug; 50(2):302-10. PubMed ID: 16759789
[TBL] [Abstract][Full Text] [Related]
34. DNA cytometry in renal cell carcinoma.
Nenning H; Rassler J; Minh DH
Gen Diagn Pathol; 1996 Mar; 141(3-4):243-7. PubMed ID: 8705789
[TBL] [Abstract][Full Text] [Related]
35. The role of radical surgery for renal cell carcinoma with extension into the vena cava.
Staehler G; Brkovic D
J Urol; 2000 Jun; 163(6):1671-5. PubMed ID: 10799157
[TBL] [Abstract][Full Text] [Related]
36. De novo papillary renal cell carcinoma in an allograft kidney: evidence of donor origin.
Naruke Y; Ito M; Mihara Y; Umezaki Y; Matsuya F; Hayashi M; Nakashima M; Khono S
Pathol Int; 2011 Nov; 61(11):694-6. PubMed ID: 22029684
[No Abstract] [Full Text] [Related]
37. [Epidemiology and pathology of malignant renal tumors].
Brühl P; Vahlensieck W
Wien Med Wochenschr; 1976 Mar; 126(13-14):169-74. PubMed ID: 983087
[No Abstract] [Full Text] [Related]
38. [Clinical application of flow cytometry in urology. 4. The role of the flow cytometric DNA-histogram as a prognostic factor of renal cell carcinomas].
Tachibana M; Jitsukawa S; Nakajima J; Iigawa T; Deguchi N; Baba S; Nakazono M; Hata M; Tazaki H
Nihon Hinyokika Gakkai Zasshi; 1987 May; 78(5):816-21. PubMed ID: 3694979
[No Abstract] [Full Text] [Related]
39. The operable renal cell carcinoma: summary and conclusions.
deKernion JB; Huland H
Eur Urol; 1990; 18 Suppl 2():48-51. PubMed ID: 2226611
[No Abstract] [Full Text] [Related]
40. [Tumor enucleation as the conservative treatment of choice for renal carcinoma].
Garritano A; Pastorina E; Santarelli E; De Rosa F
Minerva Urol Nefrol; 1995 Jun; 47(2):77-80. PubMed ID: 8560353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
